Effects of caffeine and coffee consumption on cardiovascular disease and risk factors

Future Cardiology

Volumn 3, Issue 2, 2007, Pages 203-212

  Mattioli, Anna Vittoria ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Atrial fibrillation; Caffeine; Coffee; Inflammation

Indexed keywords

CAFFEINE;

ADRENERGIC STIMULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; COFFEE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIETARY INTAKE; DISEASE MARKER; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; INSULIN SENSITIVITY; LIPID METABOLISM; META ANALYSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 33947615660     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.3.2.203     Document Type: Review

References (88)

1. Fredholm BB, Battic K, Holmen J, Nehlig A, Zvartau EE: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Rev. 61, 83-433 (1999).
2. Carrillo JA, Benitez J: Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin. Pharmacokinet. 39, 127-153 (2000).
3. McCusker RR, Goldberger BA, Cone EJ: Caffeine content of specialty coffees. J. Anal. Toxicol. 27, 520-522 (2003).
4. Mandel HG: Update on caffeine consumption, disposition and action. Food Chem. Toxicol. 40, 1231-1234 (2002).
5. McCusker RR, Fuehrlein B, Goldberger BA, Gold MS, Cone EJ: Caffeine content of decaffeinated coffee. J. Anal. Toxicol. 30, 611-613 (2006).
6. Morgan KJ, Stulte VJ, Zabik ME: Amount and dietary sources of caffeine and saccharin intake by individuals ages 5 to 18 years. Regul. Toxicol. Pharmacol. 2, 296-307 (1982).
7. Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S: Caffeine disposition after oral doses. Clin. Pharmacol. Ther. 32, 98-106 (1982).
8. van Soeren MH, Graham TE: Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal. J. Appl. Physiol. 85, 1493-1501 (1998).
9. Sprier LL, MacLean DA, Dyck J, Hultman E. Cederblad G, Graham TE: Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am. J. Physiol. 262(Pt I), E891-E898 (1992).
10. Keijzers GB, de Galan BE, Tack CJ, Smith P: Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25, 364-369 (2002).
11. Griffiths RR, Mumford GK: Caffeine - A drug of abuse? In: Psychopharmacology: The Fourth Generation of Progress. Bloom FE, Kupler DJ (Eds). Raven Press, New York, USA 1699-1713 (1995).
12. Richardson NJ, Rogers PJ, Elliman NA, O'Dell RJ: Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol. Biocbem. Behav. 52, 313-320 (1995).
13. Nikolajsen L, Larsen KM, Kierkegaard O: Effect of previous frequency of headache, duration of fasting and caffeine abstinence on perioperative headache. Br. J. Anaesth. 72, 295-297 (1994).
14. McGowan JD, Altman RE, Kanto WP Jr: Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med. J. 81, 1092-1094 (1988).
15. Goldstein A, Wallace ME: Caffeine dependence in schoolchildren? Exp. Clin. Psychopharmacol. 5, 388-392 (1997).
16. Kawachi I, Colditz GA, Stone CB: Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br. Heart J. 72, 269-275 (1994).
17. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W: Coffee, caffeine and cardiovascular disease in men. N. Engl. J. Med. 323, 1026-1032 (1990).
18. Woodward M, Tunstall-Pedoe H: Coffee and tea consumption in the Scottish Heart Health Study follow-up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J. Epidem. Community Health 53, 481-487 (1999).
19. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles X, Campos H: Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology 17, 506-511 (2006).
20. Nurminen ML, Nittynem L, Korpela R, Vapaatalo H: Coffee, caffeine and blood pressure: a critical review. Eur. J. Clin. Nutr. 53, 831-839 (1999).
21. Hammar N, Andersson T, Andersson L et al.: Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study. J. Intern. Med. 253, 653-659 (2003).
22. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto: Coffee consumption and the risk of coronary artery disease and death. Arch. Intern. Med. 160, 3393-3400 (2000).
23. Lopez-Garcia E, van Dam RM, Willett WC et al.: Coffee consumption and coronary heart disease in men and women. A prospective cohort study. Circulation 113, 2045-2053 (2006).
24. Tavani A, Bertuzzi M, Negri E, Sorbara L, La Vecchia C: Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy. Eur. J. Epidem. 17, 1131-1137 (2001).
25. Comelis MC, El-Sohemy A, Katagambe EK, Campos H: Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295, 1135-1141(2006).
26. Sudano I, Spieker L, Binggeli C et al.: Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers. Hypertension 46, 521-526 (2005).
27. Chobanian AV, Bakris GL, Black HR et al.: National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 42, 1206-1252 (2003).
28. Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC: Habitual caffeine intake and the risk of hypertension in women. JAMA 294, 2330-2335 (2005).
29. Klang MJ, Wang NY, Meoni LA et al.: Coffee intake and risk of hypertension: the John Hopkins precursors study. Arch. Intern. Med. 162, 657-662 (2002).
30. Noordzij M, Uitewaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM: Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J. Hypertens. 23, 921-928 (2005).
31. Jee SH, He J, Whelton PK, Suh I, Klag MJ: The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33, 647-652 (1999).
32. Robertson D, Frolich JC, Carr RK et al.: Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N. Engl. J. Med. 298, 181-186 (1978).
33. Corti R, Binggeli C, Sudano I et al.: Coffee acutely increases sympathetic activity and blood pressure independently of caffeine content. Role of habitual versus nonhabitual drinking. Circulation 106, 2935-2940 (2002).
34. Hamer M: Coffee and health: explaining conflicting results in hypertension. J. Hum. Hypert. 20(12), 909-912 (2006).
35. Umemura T, Ueda K, Nishioka K et al.: Effects of acute administration of caffeine on vascular function. Am. J. Cardiol. 98, 1538-1541 (2006).
36. Thelle DS, Amesen E, Forde OH: The Tromso Heart Study: does coffee raise serum cholesterol? N. Engl. J. Med. 308, 1454-1457 (1983).
37. Urgert R, Katan MB: The cholesterol-raising factor from coffee beans. Annu. Rev. Nutr. 17, 305-324 (1997).
38. Jee SH, He J, Appel LJ et al.: Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trial. Am. J. Epidemiol. 153, 353-362 (2001).
39. Gross G, Jaccaud E, Huggett AC: Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem. Toxicol. 35, 547-554 (1997).
40. de Roos B, van Tol A, Urgert R et al.: Consumption of French-press coffee raises cholesteryl ester transfer protein activity levels before LDL cholesterol in normolipidaemic subjects. J. Intern. Med. 248, 211-216 (2000).
41. Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C: Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am. J. Clin. Nutr. 80, 862-867 (2004).
42. Rodrigues IM, Klein LC: Boiled or filtered coffee? Effects of coffee and caffeine on cholesterol, fibrinogen and C-reactive Protein Toxicol. Rev. 25, 55-69 (2006).
43. Shlonsky AK, Klatsky AL, Armstrong MA: Traits of persons who drink decaffeinated coffee. Ann. Epidemiol. 13, 273-279 (2003).
44. Grubben MJ, Boers GH, Blom HJ et al.: Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am. J. Clin. Nutr. 71, 480-484 (2000).
45. Nygard O, Refsum H, Ueland PM et al.: Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am. J. Clin. Nutr. 65, 136-143 (1997).
46. Vollset SE, Nygard O, Refsum H, Ueland PM: Coffee and homocysteine. Am. J. Clin. Nutr. 71, 403-404 (2000).
47. Benowitz NL, Hall SM, Modin G: Persistent increase in caffeine concentrations in people who stop smoking. Br. Med. J. 298, 1075-76 (1989).
48. Swanson JA, Lee JW, Hopp JW: Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict. Behav. 19, 229-256 (1994).
49. Jossa F, Kogh V, Farinaro E et al.: Coffee and serum lipids: findings from the Olivetti Heart Study Ann. Epidemiol. 3, 250-255 (1993).
50. Grenberg JA, Boozer CN, Geliebter A: Coffee, diabetes, and weight control. Am. J. Clin. Nutr. 84, 682-693 (2006).
51. Salazaar-Martinez E, Willett WC, Ascherio, A et al.: Coffee consumption and risk for Type 2 diabetes mellitus. Ann. Intern. Med. 140, 1-8 (2004).
52. Keijzers GB, DeGalan BE: Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25, 364-369 (2002).
53. Battram DS, Arthur R, Weekes A, Graham T: The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J. Nutr. 136, 1276-1280 (2006).
54. Naismith DJ, Akinayanju PA, Szanto S, Yudkin J: The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr. Metabol. 12, 144-151 (1970).
55. Thong FS, Derave W, Kiens B et al.: Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduce by exercise. Diabetes 51, 583-590 (2002).
56. Wynne K, Stanley S, Bloom S: The gut and regulation of body weight. J. Clin. Endocrinol. Metab. 89, 2576-2582 (2004).
57. Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB: Changes in caffeine intake and long term weight change in men and women. Am. J. Clin. Nutr. 83, 674-680 (2006).
58. Coumel P: Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur. Heart. J. 15(Suppl. A), 9-16 (1994).
59. Hibino G, Moritani T, Kawada T, Fushiki T: Caffeine enhances modulation of parasympathetic nerve activity in humans: quantification using power spectral analysis. J. Nutr. 127, 1422-1427 (1997).
60. Sondermeijer HP, van Marie AGJ, Kamen P, Krum H: Acute effects of caffeine on heart rate variability. Am. J. Cardiol. 90, 906-907 (2002).
61. Rauh R, Burkert M, Siepmann M, Mueck-Weymann M: Acute effects of caffeine on heart rate variability in habitual caffeine consumers. Clin. Physiol. Funct. Imaging 26, 163-166 (2006).
62. Yeragani VK, Krishnan S, Engels HJ, Gretebeck R: Effects of caffeine on linear and nonlinear measures of heart rate variability before and after exercise. Depress. Anxiety 21, 130-134 (2005).
63. Bonnett M, Tancer M, Uhde T, Yeragani VK: Effects of caffeine on heart rate and QT variability during sleep. Depress. Anxiety 22, 150-155 (2005).
64. Strubelt O, Diederich KW: Experimental treatment of the acute cardiovascular toxicity of caffeine. J. Toxicol. Clin. Toxicol. 37, 29-33 (1997).
65. Price KR, Fligner DJ: Treatment of caffeine toxicity with esmolol. Ann. Emerg. Med. 19, 44-46 (1990).
66. Zimmerman PM, Pulliam J, Schwengels J, MacDonald SE: Caffeine intoxication: a near fataliy Ann. Emerg. Med. 14, 1227-1229 (1985).
67. Chou TM, Benowitz NL: Caffeine and coffee: effects on health and cardiovascular disease. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol. 109, 173-189 (1994).
68. Newcombe PF, Renton KW, Rautaharju PM, Spencer CA, Montague TJ: High-dose caffeine and cardiac rate and rhythm in normal subjects. Chest 94, 90-94 (1988).
69. Metha A, Jain AC, Metha MC, Billie M: Caffeine and cardiac arrhythmias. An experimental study in dogs with review of literature. Acta Cardiol. 52, 273-283 (1997).
70. Caron MF, Song J, Ammar R, Kluger J, White CM: An evaluation of the change in electrocardiographic P-wave variables after acute caffeine ingestion in normal volunteers. J. Clin. Pharm. Ther. 26, 145-148 (2001).
71. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF: The arrhythmogenic effects of caffeine in human beings. N. Engl. J. Med. 308, 814-816 (1983).
72. Wilhelmsen L, Rosengren A, Lappas G: Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J. Intern. Med. 250, 382-389 (2001).
73. Frost L, Vestergaard P: Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am. J. Clin. Nutr. 81, 578-582 (2005).
74. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271, 840-844 (1994).
75. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE: The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am. J. Med. 98, 476-484 (1995).
76. Mattioli AV, Bonatti S, Zennaro M, Mattioli G: The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. Europace 7(3), 211-220 (2005).
77. Mattioli AV, Tarabini Castellani E, Bonatti S, Zennaro M. Mattioli G: Effect of coffee consumption and nutritional factors in the development of acute lone atrial fibrillation. Eur. Heart. J. 13, 275 (2006).
78. Sakamoto W, Nishihira J, Fujie K et al.: Effect of coffee consumption on bone metabolism. Bone 28, 332-336 (2001).
79. Tsioufis C, Dimitriadis K, Vasiliadou C et al.: Heavy coffee consumption in conjunction with smoking is accompanied by increased inflammatory processes and impaired thrombosis/fibrinolysis system in essential hypertensive subjects. J. Hum. Hypertens. 20, 470-472 (2006).
80. Svilaas A, Sakhi AK, Andersen LF et al.: Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J. Nutr. 134, 562-567 (2004).
81. Lopez-Garcia E, van Dam RM, Qi L, Hu FB: Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am. J. Clin. Nutr. 84, 888-893 (2006).
82. Knect P, Ritz J, Pereira MA et al.: Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am. J. Clin. Nutr. 80, 1508-1520 (2004).
83. Beckman KB, Ames BN: The free radical theory of aging matures. Physiol. Rev. 78, 54-581 (1998).
84. Wild AC, Mulcahy RT: Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insight into transcriptional control of antioxidant defenses. Free Radic. Res. 32, 281-301 (2000).
85. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J. 10, 709-720 (1996).
86. Pellegrini N, Serafani M, Colombi B et al.: Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vivo assays. J. Nutr. 33, 2812-2819 (2003).
87. Daglia M, Papetti A, Gregotti C, Berte F, Gazzani G: In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J. Agric. Food Chem. 48, 1449-1454 (2000).
88. Strandhagen E. Thelle DS: Filtered coffee raises serum cholesterol: results from a controlled study Eur. J. Clin. Nutr. 57, 1164-1168 (2003).